ESF launches EuroBioFund in boost for European life sciences

16 July 2006

The Strasbourg, France-headquartered European Science Foundation has launched EuroBioFund, a new inititative that aims "to promote and coordinate interaction among European life sciences researchers and funders."

The ESF announcement notes that, "the life sciences encompass research fields that have a direct impact on the quality of our health, food and environment including pharmaceuticals, genetics, systems biology and biotechnology."

In what the Foundation refers to as the "post-genomic era," a revolution in terms of life science research approaches is underway, leading to new infrastructure needs and technology developments that will transform people's lives, the ESF says.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight